| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 126, 1860-1866, Copyright © 1990 by Endocrine Society
ARTICLES |
LJ Rosolowsky and WB Campbell
Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas 75235.
Endothelin (ET) is an endothelial cell-derived peptide with profound hemodynamic effects. We investigated the effects of ET on steroid release from bovine adrenal cortical cells. ET-1 (10(-11)-10(-6) M) did not alter basal aldosterone release from adrenal glomerulosa cells. However, both angiotensin-II (AII)- and ACTH-stimulated aldosterone release from these cells. ET-1 enhanced ACTH-stimulated aldosterone release over a range of concentrations. This enhancement was observed at a threshold of 0.1 nM ET-1. Similar responses were observed in incubations of 1- and 2-h duration. In contrast, AII-stimulated aldosterone release was not altered by ET-1. ET-1 also enhanced aldosterone release in cells stimulated with 8-bromo-cAMP. All increased cytoplasmic Ca2+ concentrations in fura-2-loaded cells; however, ET-1 alone or with ACTH had no effect. In addition, chronic treatment of cells with ACTH for 2 days caused an enhanced release of aldosterone in cells acutely treated with ET-1 compared to cells not acutely treated (62% over chronic ACTH control; P less than 0.05). However, chronic treatment of ET-1 did not alter aldosterone secretion in the acute incubation compared to that in chronic controls. Thus, both acute and chronic exposures to ACTH sensitize glomerulosa cells to stimulation by ET-1. ET-1 did not alter basal or ACTH-stimulated cortisol release from adrenal fasciculata cells. Thus, the actions of ET-1 appear to be specific for glomerulosa cells. These data indicate that ET may exert a direct effect on adrenal glomerulosa cells to enhance ACTH-stimulated aldosterone release.
This article has been cited by other articles:
![]() |
C. J. Hanke, B. B. Holmes, Y. Xu, K. Nithipatikom, and W. B. Campbell Endothelium-Derived Steroidogenic Factor Enhances Angiotensin II-Stimulated Aldosterone Release by Bovine Zona Glomerulosa Cells Endocrinology, January 1, 2007; 148(1): 317 - 323. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. X. Zhang, K. M. Gauthier, and W. B. Campbell Mechanisms of histamine-induced relaxation in bovine small adrenal cortical arteries Am J Physiol Endocrinol Metab, December 1, 2005; 289(6): E1058 - E1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Hanke and W. B. Campbell Endothelial cell nitric oxide inhibits aldosterone synthesis in zona glomerulosa cells: modulation by oxygen Am J Physiol Endocrinol Metab, October 1, 2000; 279(4): E846 - E854. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Hanke, T. O'Brien, K. A. Pritchard Jr, and W. B. Campbell Inhibition of Adrenal Cell Aldosterone Synthesis by Endogenous Nitric Oxide Release Hypertension, January 1, 2000; 35(1): 324 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Rosolowsky, C. J. Hanke, and W. B. Campbell Adrenal Capillary Endothelial Cells Stimulate Aldosterone Release through a Protein That Is Distinct from Endothelin Endocrinology, October 1, 1999; 140(10): 4411 - 4418. [Abstract] [Full Text] |
||||
![]() |
G. G. Nussdorfer, G. P. Rossi, L. K. Malendowicz, and G. Mazzocchi Autocrine-Paracrine Endothelin System in the Physiology and Pathology of Steroid-Secreting Tissues Pharmacol. Rev., September 1, 1999; 51(3): 403 - 438. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ehrhart-Bornstein, J. P. Hinson, S. R. Bornstein, W. A. Scherbaum, and G. P. Vinson Intraadrenal Interactions in the Regulation of Adrenocortical Steroidogenesis Endocr. Rev., April 1, 1998; 19(2): 101 - 143. [Abstract] [Full Text] |
||||
![]() |
S. Csukas, C. J. Hanke, D. Rewolinski, and W. B. Campbell Prostaglandin E2–Induced Aldosterone Release Is Mediated by an EP2 Receptor Hypertension, February 1, 1998; 31(2): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Elshourbagy, J. E. Adamou, A. W. Gagnon, H.-L. Wu, M. Pullen, and P. Nambi Molecular Characterization of a Novel Human Endothelin Receptor Splice Variant J. Biol. Chem., October 11, 1996; 271(41): 25300 - 25307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Belloni, G. P. Rossi, P. G. Andreis, G. Neri, G. Albertin, A. C. Pessina, and G. G. Nussdorfer Endothelin Adrenocortical Secretagogue Effect Is Mediated by the B Receptor in Rats Hypertension, May 1, 1996; 27(5): 1153 - 1159. [Abstract] [Full Text] |
||||
![]() |
E. R. Levin Endothelins N. Engl. J. Med., August 10, 1995; 333(6): 356 - 363. [Full Text] [PDF] |
||||
![]() |
G. Rossi, A. S. Belloni, G. Albertin, L. Zanin, M. A. Biasolo, G. G. Nussdorfer, G. Palu, and A. C. Pessina Endothelin-1 and Its Receptors A and B in Human Aldosterone-Producing Adenomas Hypertension, April 1, 1995; 25(4): 842 - 847. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |